SHARE

Greenwich's Nette Earn Distinguished Service Award

GREENWICH, Conn. - Barbara Netter and her late husband Edward Netter, Greenwich residents and founders of Alliance for Cancer Gene Therapy, were awarded the prestigious Distinguished Service Award by the American Society of Gene and Cell Therapy.

Alliance for Cancer Gene Therapy President and Co-Founder, Barbara Netter, left, with Dr. Savio L.C. Woo, founding chair of the group's Scientific Advisory Council and professor at the Mount Sinai School of Medicine.

Alliance for Cancer Gene Therapy President and Co-Founder, Barbara Netter, left, with Dr. Savio L.C. Woo, founding chair of the group's Scientific Advisory Council and professor at the Mount Sinai School of Medicine.

Photo Credit: Contributed

The award – presented May 22 in Washington, D.C., before a crowd of over 1,700 top scientists and research advocates – honors individuals who have fostered extraordinary progress and enhanced the field of genetic and cellular therapy.

This recognition came during the the group's 17th annual meeting, lauding the Netters for creating a foundation that has granted nearly $25 million to cancer researchers and physicians around the globe. Founded in 2001, Alliance for Cancer Gene Therapy has funded research that has saved lives, been heralded by the New York Times, and is forging an auspicious path in the effort to conquer cancer.

The American Society of Gene and Cell Therapy is a nonprofit professional and medical organization devoted to bolstering awareness and education surrounding gene and cell therapies. The organization was founded in 1996 and features 1,800 members, and publishes the medical journal Molecular Therapy. In addition to offering promise in the war against cancer, cell and gene therapies have the ability to treat cardiovascular, genetic, infectious and neural degenerative disorders. Major advancements have been made in immunotherapy for cancer, and using gene therapy treatments for inherited blindness and immune deficiencies such as SCID and hemophilia.

Established in 2001, Alliance for Cancer Gene Therapy is the nation’s only not-for-profit exclusively dedicated to cancer cell and gene therapy treatments for all types of cancer. A total of 100 percent of contributions go directly to research. ACGT has funded 44 grants in the U.S. and Canada since its founding in 2001 to conduct and accelerate critically needed innovative research for all types of cancer. Since its inception, ACGT has awarded 29 grants to Young Investigators and 15 grants to Clinical Investigators, totaling $24.7 million in funding. ACGT is located at 96 Cummings Point Road in Stamford.

For more information, visit: www.acgtfoundation.org

to follow Daily Voice Stamford and receive free news updates.

SCROLL TO NEXT ARTICLE